Home Recent Articles Funding Wrap of the Week | American Startups Funding Roundup | February 10...

Funding Wrap of the Week | American Startups Funding Roundup | February 10 – February 14

0
There are a lot of American startups funding deals that are creating buzz around the startup ecosystem. These are the growth-stage and early-stage deals of this week. Let’s talk about the Top 10 Funding deals.
There are a lot of American startups funding deals that are creating buzz around the startup ecosystem. These are the growth-stage and early-stage deals of this week. Let’s talk about the Top 10 Funding deals.
There are a lot of American startups funding deals that are creating buzz around the startup ecosystem. These are the growth-stage and early-stage deals of this week. Let’s talk about the Top 10 Funding deals.

There are a lot of American startups funding deals that are creating buzz around the startup ecosystem. These are the growth-stage and early-stage deals of this week. Let’s talk about the Top 10 Funding deals.

American Startups Funding Roundup

Abcuro

Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of cytotoxic T cells, announced the closing of a $200 million Series C financing led by New Enterprise Associates (NEA) with Foresite Capital joining the round and participation of existing investors including RA Capital Management, Bain Capital Life Sciences, Redmile Group, Samsara BioCapital, Sanofi Ventures, Pontifax, Mass General Brigham Ventures, New Leaf Ventures, funds managed by abrdn Inc., funds and accounts managed by BlackRock, Eurofarma Ventures, and Soleus Capital.

EnCharge AI 

EnCharge AI, a startup developing first-of-its-kind analog in-memory-computing AI chips, has secured over $100 million in Series B funding. This latest oversubscribed round, which brings EnCharge AI’s total funding to more than $144 million, will advance the commercialization of its first client computing-focused AI accelerator products in 2025 and progress along EnCharge’s future product roadmap.

Stellaromics

Stellaromics, a pioneer in 3D spatial biology spun out of the laboratories of Karl Deisseroth (Stanford University) and Xiao Wang (MIT and Broad Institute), announced the completion of a Series B funding round for $80Mn.

SGNL

SGNL, a fast-growing identity-first security startup has just secured $30 million in a Series A funding round to accelerate its mission of redefining how businesses protect their most critical assets.

Epicore Biosystems

Epicore Biosystems (Epicore), a digital health solutions leader developing advanced sweat-sensing wearables, has raised $26M in Series B funding led by the Steele Foundation for Hope (SFFH).

Positron

Positron, a rising force in AI inference technology for artificial intelligence computing, has raised $23.5 million in funding from investors, including Flume Ventures, Valor Equity Partners, Atreides Management, and Resilience Reserve.

Boostly

Boostly, the leading provider of automated SMS marketing and feedback solutions for restaurants, has raised $22 million in growth capital, led by PeakSpan Capital with participation from existing investors Y Combinator, Trestle Partners, and Singularity Capital.

Junevity

Junevity, a biotechnology company on a mission to extend lifespan and healthspan by resetting cell damage from age-related diseases, announced $10 million in seed funding led by Goldcrest Capital and Godfrey Capital.

Nirmata

Nirmata, a leader in cloud-native security policy automation and governance solutions, announced a $9.6 million funding round led by Peak XV Surge (formerly Sequoia Capital India & SEA), with participation from Dallas Venture Capital, Dreamit Ventures and existing investors Z5 Capital and Uncorrelated Ventures.

ACT-ion

ACT-ion Battery Technologies, a startup in the field of lithium ion battery cathode active materials (CAM), announced the successful closing of its Pre-Series A funding round. Founded in 2019, ACT-ion has developed both an efficient and cost-effective means to produce single crystalline cathode active materials.

Exit mobile version